The 2025 GenScript Virtual Summit—formerly the Gene and Cell Engineering Summit—serves as a leading international forum for scientists, biotech innovators, and pharmaceutical leaders to examine cutting-edge advances shaping the next generation of therapeutics. Over the past years, the Summit has convened thousands of researchers across academia and industry, providing a platform for scientific exchange and cross-disciplinary collaboration.

Aligned with GenScript’s renewed branding vision—“Scripting Possibilities”—this year’s Summit reflects the translational reality of modern biopharmaceutical R&D. By expanding its scope beyond gene and cell engineering to include therapeutic antibody discovery and the application of AI-driven methodologies, the Summit emphasizes the convergence of technologies that are redefining discovery pipelines, accelerating development timelines, and transforming clinical translation.

2025 Focus Themes

1. AI-Driven Drug Discovery: from in-silico hit identification and molecular design to clinical candidate optimization

2. Next-Generation Gene & Cell Engineering: CRISPR 3.0, precision base-editing systems, in-vivo delivery modalities

3. Therapeutic Antibody Innovation: synthetic library platforms, de novo protein design, and multi-specific antibody formats

4. Translational & Regulatory Frontiers: IND-enabling data strategies, advanced CMC considerations, and global regulatory harmonization

Learning Objectives:

• Explore cutting-edge applications of CRISPR, base editing, and cell therapy in next-gen biotherapeutics.

• Master AI/ML integration into antibody design, gene synthesis, and preclinical development workflows.

• Build cross-disciplinary collaborations to accelerate translational research from bench to clinic.